Drug intelligence / Profile preview

lixu jieyu fang

Development stage
Unknown
Administration
Oral
01

Overview

Lixu Jieyu Fang (LJR) is a Traditional Chinese Medicine (TCM) herbal decoction used for the treatment of Chronic Fatigue Syndrome (CFS). The formula is a combination of eight herbs: milkvetch root (*Astragalus membranaceus*), kudzuvine root (*Pueraria lobata*), asiabell root (*Codonopsis pilosula*), red sage root (*Salvia miltiorrhiza*), aizoon stonecrop (*Sedum aizoon*), epimedium herb (*Epimedium brevicornu*), curcuma root (*Curcuma longa*), and grassleaved sweetflag rhizome (*Acorus tatarinowii*). It is prepared as a 200 mL decoction and administered orally. Its therapeutic effect is attributed to its ability to modulate the immune system, specifically by regulating serum immunoglobulin levels (IgG, IgA, IgM, IgE) and balancing T-lymphocyte subsets (CD4/CD8 ratio). Clinical research in China, including a randomized study of 75 patients, has indicated its potential to alleviate both physical and mental fatigue associated with CFS.

Other names
Lixu Jieyu RecipeLixu Jieyu Formula理虚解郁方
02

Targets

CD4 (T lymphocyte surface antigen)CD8A (CD8 alpha/beta Coreceptor)IgA (Immunoglobulin A)IgE (Immunoglobulin E)IgM (Immunoglobulin M)

Beyond the preview

Go deeper on lixu jieyu fang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on lixu jieyu fang.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call